MME
CVS icon

Meag Munich Ergo’s CVS Health CVS Stock Holding History

Meag Munich Ergo’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-5,000
Closed -$339K – 321
2020
Q4 		$339K Sell
5,000
-5,000
-50% -$325K 0.08% 168
2020
Q3 		$584K Buy
+10,000
New +$622K 0.11% 158
2020
Q1 		– Sell
-19,938
Closed -$1.47M – 277
2019
Q4 		$1.47M Sell
19,938
-65,938
-77% -$4.63M 0.16% 145
2019
Q3 		$5.31M Buy
85,876
+26,168
+44% +$1.55M 0.27% 90
2019
Q2 		$3.27M Buy
59,708
+10,000
+20% +$539K 0.26% 94
2019
Q1 		$2.65M Buy
+49,708
New +$3.07M 0.22% 106
2018
Q4 		– Sell
-115,058
Closed -$9.01M – 354
2018
Q3 		$9.01M Sell
115,058
-3,336
-3% -$239K 0.53% 53
2018
Q2 		$7.85M Buy
+118,394
New +$7.8M 0.49% 58
2018
Q1 		– Sell
-89,491
Closed -$6.58M – 416
2017
Q4 		$6.58M Sell
89,491
-130,526
-59% -$9.49M 0.25% 115
2017
Q3 		$17.9M Buy
220,017
+154,286
+235% +$12.2M 0.73% 37
2017
Q2 		$5.27M Sell
65,731
-40,887
-38% -$3.23M 0.23% 138
2017
Q1 		$8.38M Buy
106,618
+21,591
+25% +$1.72M 0.33% 109
2016
Q4 		$6.75M Buy
+85,027
New +$6.88M 0.31% 115
2016
Q2 		– Sell
-31,735
Closed -$3.29M – 187
2016
Q1 		$3.29M Buy
+31,735
New +$3.09M 0.17% 144
2015
Q3 		– Sell
-84,117
Closed -$8.86M – 237
2015
Q2 		$8.86M Sell
84,117
-57,691
-41% -$5.89M 0.46% 76
2015
Q1 		$14.7M Sell
141,808
-38,890
-22% -$3.94M 0.71% 45
2014
Q4 		$17.6M Buy
180,698
+6,672
+4% +$588K 0.8% 38
2014
Q3 		$13.8M Sell
174,026
-7,751
-4% -$611K 0.64% 47
2014
Q2 		$13.8M Buy
181,777
+37,602
+26% +$2.84M 0.6% 53
2014
Q1 		$10.8M Sell
144,175
-5,276
-4% -$373K 0.8% 42
2013
Q4 		$10.7M Sell
149,451
-100,223
-40% -$6.44M 0.63% 45
2013
Q3 		$14.3M Buy
249,674
+199,173
+394% +$11.9M 1.01% 31
2013
Q2 		$2.9M Buy
+50,501
New +$2.93M 0.22% 116

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Meag Munich Ergo's CVS Position: Q1 2021 in Review

Meag Munich Ergo sold out of CVS Health (CVS) in Q1 2021, closing a stake of 5,000 shares — an estimated $339K sold.

Meag Munich Ergo first reported a position in CVS in Q2 2013 and held it in 23 quarters. The position peaked at $17.9M in Q3 2017. 2,032 funds tracked by Wall St. Rank hold CVS as of Q1 2021.

  • Meag Munich Ergo reported no remaining CVS Health position as of Q1 2021 after selling out during the quarter.
  • Meag Munich Ergo sold 5,000 CVS Health shares in Q1 2021, an estimated $339K.
  • Meag Munich Ergo first reported a position in CVS Health in Q2 2013 and held it in 23 quarters.
  • Meag Munich Ergo's CVS Health position peaked at $17.9M in Q3 2017.
  • 2,032 funds tracked by Wall St. Rank held CVS Health as of Q1 2021.

Based on Meag Munich Ergo's 13F filing for Q1 2021, filed 20 Apr 2021.